Spinal muscular atrophy  community-oneSMAvoice

If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.

oneSMAvoice
  • Social Wall
  • Trusted Resources
    • EducationScientific literature & patient education texts
    • People & PlacesHealthcare providers, researchers, & advocates
    • Community CenterOnline groups, photo galleries, & blogs
    • News & MeetingsLatest announcements & gatherings
    • Videos & VisualsChannels, infographics, & slides
  • Clinical Trial Education
Global Search
Global Search
  • Social Wall Social Wall
  • Trusted Resources Trusted Resources
    • Trusted Resources Home

    • Education

      Scientific literature & patient education texts
    • People & Places

      Healthcare providers, researchers, & advocates
    • Community Center

      Online groups, photo galleries, & blogs
    • News & Meetings

      Latest announcements & gatherings
    • Videos & Visuals

      Channels, infographics, & slides
  • rareClinical Clinical Trial Education
  • my Account
Global Search
Log in
Register
en English
en Englishes Spanish
  • Register
  • Log in
en English
en Englishes Spanish

    contact us
    have a question, issue or just some feedback for us? we're here for you.



    DISCLAIMER

    The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
    compose your message

      *

      *


      message

      *

      message sent

      email sent successfully

      suggest a poll

      you must have an account to suggest polls.

      join now

      rareLife solutions 606 Post Road East #397
      Westport, CT 06880
      You are receiving this because you have an account on www.oneSMAvoice.com
      If you'd like to unsubscribe and stop receiving these emails click here

      Trusted Resources: News & Meetings

      Latest announcements and gatherings

      • Clinical Trial and Research
      • Business
      • People
      • Spotlight
      • Happenings
      Back to News & Meetings / Business

      Biogen Exercises Option With Ionis to Develop and Commercialize Investigational ASO for SMA


      Biogen, Inc. and Ionis Pharmaceuticals, Inc. announced that Biogen exercised its option to obtain from Ionis a worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB115/ION306. The companies have a broad strategic collaboration to develop novel therapies to treat neurological disorders. BIIB115 is an investigational antisense oligonucleotide (ASO) in development for spinal muscular atrophy (SMA) that may have the potential to help address additional unmet needs of patients as well as to be administered at extended dosing intervals. Biogen plans to advance BIIB115 to clinical trials to investigate safety, tolerability, pharmacokinetics, and efficacy.

      “Combining Biogen’s expertise in neurology with Ionis’ leadership in antisense technology has led to SPINRAZA® (nusinersen) being a foundation of care in SMA,” said Toby Ferguson, M.D., Ph.D., Vice President and Head of the Neuromuscular Development Unit at Biogen.

      Biogen Exercises Option With Ionis To Develop And Commercialize Investigational ASO For SMA
      Source: https://www.biospace.com/article/releases/biogen-exercises-option-with-ionis-to-develop-and-commercialize-investigational-aso-for-sma/
      Share
      Discuss in Social Wall
      Share to rareTeam
      Bookmark

      Related Content

      • News & Meetings
        Biogen to Launch Study of Higher Spinraza Dose in Patients With Later Onset SMA
        Biogen announced it intends to initiate ...
      • Education
        Spinal Muscular Atrophy Patient iPSC-Derived Motor Neurons Display Altered Proteomes at Early Stages of Differentiat...
        Spinal muscular atrophy (SMA) is an auto...
      • News & Meetings
        New Treatment Can Help Fresno Infant With Rare Genetic Disorder
        A Fresno family is holding onto hope aft...
      • Education
        Comparative All-Cause Mortality Among a Large Population of Patients With Spinal Muscular Atrophy Versus Matched Con...
        Introduction: There is little informatio...
      • News & Meetings
        FDA Lifts Partial Clinical Hold on Novartis’ SMA Drug Programme
        The US Food and Drug Administration (FDA...
      • News & Meetings
        Scholar Rock Provides Corporate Update and Highlights Priorities for 2022
        Scholar Rock, a clinical-stage biopharma...
      • People & Places
        Karen S. Chen, PhD
        Karen Chen is the Chief Executive Office...

      send a message

      send to:
      subject:
      message:
      Back to Top
      edit tags:

      Reset password

      Enter Phone Number

      Enter the code

      Almost done!
      We just send a four digit code to your mobile number. Enter it here to login!
      Didn't receive the code?Re-send
      Or login in with your password instead

      password changed successfully!

      oneSMAvoice

      please log in with your email address and new password.

      your activation key expired

      oneSMAvoice

      this confirmation key has expired. please try to log in again or resend confirmation email.

      confirmation email sent

      oneSMAvoice

      a confirmation email has been sent to your inbox. click the link in the email to activate your account.
      can't find the email? be sure to check your spam folder.

      password reset email sent

      oneSMAvoice

      an email has been sent to you with a link to reset your password.
      can't find the email? be sure to check your spam folder.

      oneSMAvoice

      If you are a doctor or other qualified health care professional, you should not offer any medical advice or treatment on our Sites, nor should you allow the content of our Sites to substitute for your own medical judgment. Please thoroughly review the information provided on our Sites before deciding whether any of the products, services, or treatments therein are right for you or others.

      your account is now activated!

      oneSMAvoice
      • register
      • log in

      Join the community

      You need an account to use this feature.

      Already have an account? Log in.

      I have read and understand the oneSMAvoice privacy policy and terms of use.

      Almost done!
      We just sent a four digit code to your mobile number. Enter it here to log in!
      Please Wait!!!
      Didn't receive the code? Re-send
      Or log in in with your password instead

      Log in

      You need to log in to use this feature.

      Don't have an account? Click here to register.

      you haven't confirmed your email address yet. resend confirmation email

      Forget your password? Reset here.
      Or log in with a one-time code
      or register with

      login with:


      Need to get in touch?

      Powered by

      In partnership with

      • About Us
      • FAQs
      • Legal & Privacy
      • Contact Us
      © 2023 rareLife solutions Inc.